Source:http://linkedlifedata.com/resource/pubmed/id/12755155
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-5-19
|
pubmed:abstractText |
Some of the important developments in breast cancer treatment and biology are highlighted from presentations made at the 25th San Antonio Breast Cancer Symposium 2002 (San Antonio, Texas, 11-14 December 2002). These include an updated analysis of the ATAC trial, new data demonstrating the superiority of dose-dense adjuvant chemotherapy over conventional scheduling, and recent developments in the field of proteomics.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-7995
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
143-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
2003
|
pubmed:articleTitle |
Recent advances in breast cancer: the 25th Annual San Antonio Breast Cancer Symposium.
|
pubmed:affiliation |
Brunel Institute of Cancer Genetics, Brunel University, Uxbridge, UK. kefahmokbel@hotmail.com
|
pubmed:publicationType |
Congresses
|